Novel analogs of antitumor agent calixarene 0118: Synthesis, cytotoxicity, click labeling with 2-[18F]fluoroethylazide, and in vivo evaluation
- 1 January 2015
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 89, 279-295
Abstract
No abstract availableKeywords
Funding Information
- Center for Translational Molecular Medicine
- Mammary Carcinoma Molecular Imaging for Diagnosis and Therapeutics
This publication has 41 references indexed in Scilit:
- Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancerInvestigational New Drugs, 2013
- Compilation of 222 drugs’ plasma protein binding data and guidance for study designsDrug Discovery Today, 2012
- A review of Judah Folkman's remarkable achievements in biomedicineProceedings of the National Academy of Sciences, 2008
- Scheduling of Radiation with Angiogenesis Inhibitors Anginex and Avastin Improves Therapeutic Outcome via Vessel NormalizationClinical Cancer Research, 2007
- Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapyProceedings of the National Academy of Sciences, 2006
- beta-Sheet is the bioactive conformation of the anti-angiogenic anginex peptideBiochemical Journal, 2003
- The designer antiangiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal modelsThe FASEB Journal, 2002
- A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective “Ligation” of Azides and Terminal AlkynesAngewandte Chemie International Edition, 2002
- Synthesis of Calix[4]arenes with Four Different “Lower Rim” SubstituentsThe Journal of Organic Chemistry, 1999
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971